secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2025-10-31T23:59:59+00:00
Accession:  0001628280-25-047855
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics prices $4M registered direct offering of 5M shares at $0.80
--------------------------------------------------------------------------------

- Gross proceeds of $4.0M from sale of 5M shares at $0.80 per share; closing expected Nov 3, 2025.
- Net proceeds to fund clinical trial advancement, working capital, and general corporate purposes.
- Cash runway expected to extend to end of Q1 2027 after the offering closes.
- A.G.P./Alliance Global Partners is sole placement agent; fee 7% of gross proceeds plus up to $50k expenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000162828025047855/0001628280-25-047855-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000162828025047855/intensity-20251030.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-047855

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer